Raffles Medical Group Ltd (RAFLF)
Raffles Medical Ltd Statistics
Share Statistics
Raffles Medical Ltd has 1.86B shares outstanding. The number of shares has increased by 0.04% in one year.
| Shares Outstanding | 1.86B |
| Shares Change (YoY) | 0.04% |
| Shares Change (QoQ) | 0.04% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 709.15M |
| Failed to Deliver (FTD) Shares | - |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is 27.3 and the forward PE ratio is null. Raffles Medical Ltd's PEG ratio is -0.88.
| PE Ratio | 27.3 |
| Forward PE | n/a |
| PS Ratio | 2.26 |
| Forward PS | n/a |
| PB Ratio | 1.62 |
| P/FCF Ratio | 26 |
| PEG Ratio | -0.88 |
Enterprise Valuation
Raffles Medical Ltd has an Enterprise Value (EV) of 1.44B.
| EV / Sales | 1.92 |
| EV / EBITDA | 10.63 |
| EV / EBIT | 16.74 |
| EV / FCF | 22.09 |
Financial Position
The company has a current ratio of 1.35, with a Debt / Equity ratio of 0.08.
| Current Ratio | 1.35 |
| Quick Ratio | 1.32 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | 0.65 |
| Debt / FCF | 1.35 |
| Interest Coverage | 14.27 |
Financial Efficiency
Return on Equity is 5.93% and Return on Invested Capital is 5.07%.
| Return on Equity | 5.93% |
| Return on Assets | 4.07% |
| Return on Invested Capital | 5.07% |
| Revenue Per Employee | $251.44K |
| Profits Per Employee | $20.82K |
| Employee Count | 2,989 |
| Asset Turnover | 0.49 |
| Inventory Turnover | 24.66 |
Taxes
| Income Tax | 24.68M |
| Effective Tax Rate | 28.38% |
Stock Price Statistics
The stock price has increased by -18.92% in the last 52 weeks. The beta is 0.38, so Raffles Medical Ltd's price volatility has been higher than the market average.
| Beta | 0.38 |
| 52-Week Price Change | -18.92% |
| 50-Day Moving Average | 0.6 |
| 200-Day Moving Average | 0.65 |
| Relative Strength Index (RSI) | 6.2 |
| Average Volume (20 Days) | 448 |
Income Statement
In the last 12 months, Raffles Medical Ltd had revenue of 751.56M and earned 62.24M in profits. Earnings per share was 0.03.
| Revenue | 751.56M |
| Gross Profit | 486.14M |
| Operating Income | 82.49M |
| Net Income | 62.24M |
| EBITDA | 135.83M |
| EBIT | 92.74M |
| Earnings Per Share (EPS) | 0.03 |
Balance Sheet
The company has 343.67M in cash and 88.17M in debt, giving a net cash position of 255.5M.
| Cash & Cash Equivalents | 343.67M |
| Total Debt | 88.17M |
| Net Cash | 255.5M |
| Retained Earnings | 609.96M |
| Total Assets | 1.53B |
| Working Capital | 134.38M |
Cash Flow
In the last 12 months, operating cash flow was 86.25M and capital expenditures -20.91M, giving a free cash flow of 65.34M.
| Operating Cash Flow | 86.25M |
| Capital Expenditures | -20.91M |
| Free Cash Flow | 65.34M |
| FCF Per Share | 0.04 |
Margins
Gross margin is 64.68%, with operating and profit margins of 10.98% and 8.28%.
| Gross Margin | 64.68% |
| Operating Margin | 10.98% |
| Pretax Margin | 11.57% |
| Profit Margin | 8.28% |
| EBITDA Margin | 18.07% |
| EBIT Margin | 10.98% |
| FCF Margin | 8.69% |
Dividends & Yields
RAFLF pays an annual dividend of $0.04, which amounts to a dividend yield of 3.18%.
| Dividend Per Share | $0.04 |
| Dividend Yield | 3.18% |
| Dividend Growth (YoY) | 7.71% |
| Payout Ratio | 122.71% |
| Earnings Yield | 3.66% |
| FCF Yield | 3.85% |
Analyst Forecast
Currently there are no analyst rating for RAFLF.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on May 9, 2016. It was a forward split with a ratio of 3:1.
| Last Split Date | May 9, 2016 |
| Split Type | forward |
| Split Ratio | 3:1 |
Scores
| Altman Z-Score | 2.72 |
| Piotroski F-Score | 6 |